愛朋醫療(300753.SZ):愛朋發展擬認購天峯揚帆2500萬元基金份額
格隆匯3月11日丨愛朋醫療(300753.SZ)公佈,公司全資子公司江蘇愛朋醫療科技發展有限公司(以下簡稱“愛朋發展”)於2021年3月簽署了《北京天峯揚帆股權投資合夥企業(有限合夥)合夥協議》,擬使用自有資金2500萬元,認購北京天峯揚帆股權投資合夥企業(有限合夥)(以下簡稱“天峯揚帆”“投資基金”)份額,成為投資基金的有限合夥人。投資基金的普通合夥人、管理人和執行事務合夥人為北京天峯德暉投資管理有限公司(以下簡稱“天峯德暉”)。
愛朋發展參與設立投資基金,主要目的是充分藉助專業投資機構的優質資源及其投資管理優勢,增強上市公司的核心競爭力和持續盈利能力,並通過對外投資實現資本增值,為公司股東創造經濟效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.